MEDP PE Ratio & Valuation,Is MEDP Overvalued

MEDP Relative Valuation

MEDP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MEDP is overvalued; if below, it's undervalued.

Historical Valuation

Medpace Holdings Inc (MEDP) is now in the Fair zone, suggesting that its current forward PE ratio of 34.02 is considered Fairly compared with the five-year average of 30.13. The fair price of Medpace Holdings Inc (MEDP) is between 478.82 to 623.54 according to relative valuation methord.

Relative Value

Fair Zone

478.82-623.54

Current Price：559.13

Fair

34.02

26.28

EV/EBITDA

Medpace Holdings Inc. (MEDP) has a current EV/EBITDA of 26.28. The 5-year average EV/EBITDA is 22.46. The thresholds are as follows: Strongly Undervalued below 14.75, Undervalued between 14.75 and 18.61, Fairly Valued between 26.32 and 18.61, Overvalued between 26.32 and 30.18, and Strongly Overvalued above 30.18. The current Forward EV/EBITDA of 26.28 falls within the Historic Trend Line -Fairly Valued range.

27.66

EV/EBIT

Medpace Holdings Inc. (MEDP) has a current EV/EBIT of 27.66. The 5-year average EV/EBIT is 24.39. The thresholds are as follows: Strongly Undervalued below 15.79, Undervalued between 15.79 and 20.09, Fairly Valued between 28.70 and 20.09, Overvalued between 28.70 and 33.00, and Strongly Overvalued above 33.00. The current Forward EV/EBIT of 27.66 falls within the Historic Trend Line -Fairly Valued range.

5.67

Medpace Holdings Inc. (MEDP) has a current PS of 5.67. The 5-year average PS is 4.50. The thresholds are as follows: Strongly Undervalued below 2.82, Undervalued between 2.82 and 3.66, Fairly Valued between 5.33 and 3.66, Overvalued between 5.33 and 6.17, and Strongly Overvalued above 6.17. The current Forward PS of 5.67 falls within the Overvalued range.

22.49

P/OCF

Medpace Holdings Inc. (MEDP) has a current P/OCF of 22.49. The 5-year average P/OCF is 21.45. The thresholds are as follows: Strongly Undervalued below 13.68, Undervalued between 13.68 and 17.56, Fairly Valued between 25.33 and 17.56, Overvalued between 25.33 and 29.22, and Strongly Overvalued above 29.22. The current Forward P/OCF of 22.49 falls within the Historic Trend Line -Fairly Valued range.

24.62

P/FCF

Medpace Holdings Inc. (MEDP) has a current P/FCF of 24.62. The 5-year average P/FCF is 24.39. The thresholds are as follows: Strongly Undervalued below 14.33, Undervalued between 14.33 and 19.36, Fairly Valued between 29.42 and 19.36, Overvalued between 29.42 and 34.44, and Strongly Overvalued above 34.44. The current Forward P/FCF of 24.62 falls within the Historic Trend Line -Fairly Valued range.

Medpace Holdings Inc (MEDP) has a current Price-to-Book (P/B) ratio of 54.46. Compared to its 3-year average P/B ratio of 23.51 , the current P/B ratio is approximately 131.69% higher. Relative to its 5-year average P/B ratio of 17.92, the current P/B ratio is about 203.93% higher. Medpace Holdings Inc (MEDP) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 4.88%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 4.62% , the current FCF yield is about -100.00% lower.

54.46

P/B

Median3y

23.51

Median5y

17.92

4.31

FCF Yield

Median3y

4.88

Median5y

4.62

Competitors Valuation Multiple

The average P/S ratio for MEDP's competitors is , providing a benchmark for relative valuation. Medpace Holdings Inc Corp (MEDP) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 23.74%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of MEDP increased by 68.30% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 25.79 to 39.05.

The secondary factor is the Revenue Growth, contributed 23.74%to the performance.

Overall, the performance of MEDP in the past 1 year is driven by P/E Change. Which is more unsustainable.

23.74%

533.32M → 659.90M

Revenue Growth

-6.86%

18.08 → 16.84

Margin Expansion

51.42%

25.79 → 39.05

P/E Change

68.30%

332.23 → 559.13

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Medpace Holdings Inc (MEDP) currently overvalued or undervalued?

What is Medpace Holdings Inc (MEDP) fair value?

MEDP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Medpace Holdings Inc (MEDP) is between 478.82 to 623.54 according to relative valuation methord.

How does MEDP's valuation metrics compare to the industry average?

What is the current P/B ratio for Medpace Holdings Inc (MEDP) as of Dec 16 2025?

As of Dec 16 2025, Medpace Holdings Inc (MEDP) has a P/B ratio of 54.46. This indicates that the market values MEDP at 54.46 times its book value.

What is the current FCF Yield for Medpace Holdings Inc (MEDP) as of Dec 16 2025?

As of Dec 16 2025, Medpace Holdings Inc (MEDP) has a FCF Yield of 0.00%. This means that for every dollar of Medpace Holdings Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Medpace Holdings Inc (MEDP) as of Dec 16 2025?

As of Dec 16 2025, Medpace Holdings Inc (MEDP) has a Forward P/E ratio of 34.02. This means the market is willing to pay $34.02 for every dollar of Medpace Holdings Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Medpace Holdings Inc (MEDP) as of Dec 16 2025?

As of Dec 16 2025, Medpace Holdings Inc (MEDP) has a Forward P/S ratio of 0.00. This means the market is valuing MEDP at $0.00 for every dollar of expected revenue over the next 12 months.

MEDP Valuation